Tarsus Pharmaceuticals, Inc. (TARS) › Operating Cash FlowTarsus Pharmaceuticals, Inc. (TARS) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2019: -$3.67M2020: -$21.14M2021: $3.75M2022: -$49.03M2023: -$117.49M2024: -$83.03M2025: -$12.45M-$12.45M2019Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$12.45M+85.0%2024-$83.03M+29.3%2023-$117.49M-139.6%2022-$49.03M-1408.2%2021$3.75M+117.7%2020-$21.14M-475.5%2019-$3.67M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share